Skip to content
10-Q

Quarterly Report

Q BIOMED INC.

0001410578-22-000915

← back to feed
Filed
Apr 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Apr 11, 2022 31.43M sh
Short Term Debt Q1 2022 · Feb 28, 2022 $3.35M
Short Term Debt Q1 2022 · Nov 30, 2021 $3.05M
Current Liabilities Q1 2022 · Feb 28, 2022 $6.37M
Current Liabilities Q1 2022 · Nov 30, 2021 $5.49M
Total Liabilities Q1 2022 · Feb 28, 2022 $6.37M
Total Liabilities Q1 2022 · Nov 30, 2021 $5.49M
Current Assets Q1 2022 · Feb 28, 2022 $200.93K
Current Assets Q1 2022 · Nov 30, 2021 $459.48K
Total Assets Q1 2022 · Feb 28, 2022 $538.43K
Total Assets Q1 2022 · Nov 30, 2021 $809.48K
Shares Diluted Q1 2022 · Feb 28, 2021 24.64M sh
Operating Cash Flow Q1 2022 · Feb 28, 2021 −$817.02K
Stockholders Equity Q1 2022 · Feb 28, 2021 −$1.79M
Stockholders Equity Q1 2022 · Nov 30, 2020 −$1.08M
Eps Diluted Q1 2022 · Feb 28, 2021 −$0.11
Eps Basic Q1 2022 · Feb 28, 2021 −$0.11
Rd Expense Q1 2022 · Feb 28, 2021 $173.43K
Net Income Q1 2022 · Feb 28, 2021 −$2.48M
Gross Profit Q1 2022 · Feb 28, 2021 −$40.59K
Cost Of Revenue Q1 2022 · Feb 28, 2021 $40.59K